Clearmind medicine inc.CMND.US Overview

US StockHealthcare

(No presentation for CMND)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

CMND Overall Performance

CMND AI Analysis & Strategy

CMND Recent Performance

-1.34%

Clearmind medicine inc.

0.81%

Avg of Sector

-1.14%

S&P500

CMND PowerScanner

CMND Key Information

CMND Valuation Metrics

CMND Earnings Table

CMND Profile

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.